03/01
Headlines

NASDAQ:FLXN

Market Alert: Halliburton Company (NYSE:HAL), FuelCell Energy Inc. (NASDAQ:FCEL), Flexion Therapeutics, Inc. (NASDAQ:FLXN), Zoetis Inc. (NYSE:ZTS), Denbury Resources Inc. (NYSE:DNR)

Kevin Long03 mins

Halliburton Co. (NYSE: HAL) and Baker Hughes Inc. (NYSE: BHI) on Dec. 22 released a slew of details related to the Houston-based oilfield services companies’ pending acquisition deal. Halliburton Company (NYSE:HAL) belongs to Basic Materials sector. Its net profit margin is 10.70% and weekly performance is 1.27%. On last trading day company shares ended up…

Read More

Morning Watch List: Kandi Technolgies (NASDAQ:KNDI), QUALCOMM (NASDAQ:QCOM), Teekay Offshore Partners (NYSE:TOO), Flexion Therapeutics (NASDAQ:FLXN), Avon Products Inc. (NYSE:AVP)

Kristen Barton03 mins

On July 30,2014 Kandi Technologies Group, Inc. (Nasdaq:KNDI), announced that, due to the high demand for EV charging and parking facilities in Hangzhou city, Zhejiang province in China, on-street EV charging/parking stations have been added to the Hangzhou Car-Share Program network to meet the needs of the Car-Share Program participants.  Kandi Technolgies Group, Inc. (NASDAQ:KNDI)…

Read More

Healthcare Stocks In News: Ultragenyx (NASDAQ:RARE), Flexion (NASDAQ:FLXN), Receptos Inc (NASDAQ:RCPT), Acorda Therapeutics (NASDAQ:ACOR), Aratana Therapeutics (NASDAQ:PETX)

Mark DeFrance03 mins

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) is up over 16% today on news of the company’s initiation of phase-II trials for its lead drug candidate KRN23, which is a monoclonal antibody for X-linked Hypophosphatemia (XLH). Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) stock performance was 14.30% in last session and finished the day at $48.67. Traded volume was 435,645.00million shares…

Read More

Healthcare Bullish Stocks: Reliv International (NASDAQ:RELV), Flexion Therapeutics (NASDAQ:FLXN), Relypsa Inc (NASDAQ:RLYP), Sucampo Pharmaceuticals (NASDAQ:SCMP)

Jason Knox02 mins

Reliv International, Inc (NASDAQ:RELV) reported net sales of $14.5 million for the first quarter of 2014, compared to net sales of $18.9 million for the first quarter of 2013. Net sales in the United States declined by 29.2 percent for the quarter compared to the same quarter in 2013. Reliv International, Inc (NASDAQ:RELV) stock performance…

Read More

Drug Manufacturers Most Volatile: TherapeuticsMD Inc (NYSEMKT:TXMD), Pacira Pharmaceuticals (NASDAQ:PCRX), Heron Therapeutics Inc (NASDAQ:HRTX), Flexion Therapeutics (NASDAQ:FLXN)

Mark DeFrance02 mins

TherapeuticsMD, Inc. (NYSEMKT:TXMD), a women’s healthcare company, will host a conference call and live audio webcast to disclose its financial results for the quarter ended March 31, 2014. The call and webcast will be held on Monday, May 5, 2014 at 4:30pm EDT and will be hosted by Robert Finizio, Co-Founder and Chief Executive Officer,…

Read More